Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: A randomized controlled study

Journal of International Medical Research

Volumn 38, Issue 4, 2010, Pages 1436-1441

  Navanimitkul, N ^a   Lojanapiwat, B ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Quality of life; Stent related symptoms; Tamsulosin; Ureteral stent

Indexed keywords

TAMSULOSIN;

ADULT; ARTICLE; BALLOON DILATATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EQUIPMENT DESIGN; FEMALE; HEADACHE; HEALTH STATUS; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; PAIN ASSESSMENT; PERCUTANEOUS NEPHROLITHOTOMY; POSTOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TREATMENT DURATION; URETER STENT; URETEROSCOPY; URINARY TRACT OBSTRUCTION;

EID: 77957742682     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800425     Document Type: Article

References (20)

1. Chew BH, Knudsen BE, Denstedt JD: The use of stents in contemporary urology. Curr Opin Urol 2004; 14: 111-115.
2. Joshi HB, Newns N, Stainthorpe A, et al: Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 2003; 169: 1060-1064.
3. Richter S, Ringel A, Shalev M, et al: The indwelling ureteric stent: a 'friendly' procedure with unfriendly high morbidity. BJU Int 2000; 85: 408-411.
4. Joshi HB, Stainthorpe A, Keeley FX Jr, et al: Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol 2001; 15: 151-154.
5. Sigala S, Dellabella M, Milanese G, et al: Evidence for the presence of α1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn 2005; 24: 142-148.
6. Deliveliotis C, Chrisofos M, Gougousis E, et al: Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006; 67: 35-39.
7. Bouchelouche K, Andersen L, Alvarez S, et al: Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the α1A and α1D-adrenergic receptor antagonist tamsulosin. J Urol 2005; 173: 657-661.
8. Michel MC, Mehlbuurger L, Bressel HU, et al: Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does comorbidity alter tolerability? J Urol 1998; 160: 784-791.
9. Schulman CC, Lock TM, Buzelin JM, et al: Longterm use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia. J Urol 2001; 166: 1358-1363.
10. Küpeli B, Irkilata L, Gürocak S, et al: Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 2004; 64: 1111-1115.
11. Porpiglia F, Ghignone G, Fiori C, et al: Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004; 172: 568-571.
12. Cockett ATK, Aso Y, Denis L, et al. On behalf of the members of the committees: Recommendations of the International Consensus Committee. In: Proceedings of The Second International Consultation on Benign Prostatic Hyperplasia (BPH) (Cockett ATK, Aso Y, Chatelain C, et al, eds). Paris: Pitié Salpêtrière, 1993; pp553-564.
13. Ziebland S: The short form 36 health status questionnaire: clues from the Oxford region's normative data about its usefulness in measuring health gain in population surveys. J Epidemiol Community Health 1995; 49: 102-105.
14. Denstedt JD, Reid G, Sofer M: Advances in ureteral stent technology. World J Urol 2000; 18: 237-242.
15. Beiko DT, Knudsen BE, Denstedt JD: Advances in ureteral stent design. J Endourol 2003; 17: 195-199.
16. Candela JV, Bellman GC: Ureteral stents: impact of diameter and composition on patient symptoms. J Endourol 1997; 11: 45-47.
17. Thomas R: Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol 1993; 7: 137-140.
18. Wang CJ, Huang SW, Chang CH: Effects of specific α-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res 2009; 37: 147-152.
19. Damiano R, Autorino R, De Sio M, et al: Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 2008; 22: 651-656.
20. Joshi HB, Stainthorpe A, MacDonagh RP, et al: Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003; 169: 1065-1069.